IGF binding proteins in cancer: mechanistic and clinical insights

The six members of the family of insulin-like growth factor (IGF) binding proteins (IGFBPs) were originally characterized as passive reservoirs of circulating IGFs, but they are now understood to have many actions beyond their endocrine role in IGF transport. IGFBPs also function in the pericellular and intracellular compartments to regulate cell growth and survival — they interact with many proteins, in addition to their canonical ligands IGF-I and IGF-II. Intranuclear roles of IGFBPs in transcriptional regulation, induction of apoptosis and DNA damage repair point to their intimate involvement in tumour development, progression and resistance to treatment. Tissue or circulating IGFBPs might also be useful as prognostic biomarkers.

[1]  J. Silha,et al.  Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. , 2006, Endocrinology.

[2]  F. Tang,et al.  Cellular growth inhibition by IGFBP‐3 and TGF‐β1 requires LRP‐1 , 2003 .

[3]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.

[4]  P. Cohen,et al.  Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3. , 2006, Cancer research.

[5]  R. Rabkin,et al.  Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. , 1997, Endocrinology.

[6]  Ting-feng Wu,et al.  IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder , 2013, Journal of Clinical Pathology.

[7]  R. Baxter,et al.  Insulin-like growth factor-binding protein-1: A role in glucose counterregulation? , 1991, Molecular and Cellular Endocrinology.

[8]  Bin Tean Teh,et al.  Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. , 2005, International journal of oncology.

[9]  W. Campana,et al.  LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system. , 2014, The American journal of pathology.

[10]  S. Li,et al.  A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import. , 2008, Endocrinology.

[11]  P. Brown,et al.  Rexinoid-induced Expression of IGFBP-6 Requires RARβ-dependent Permissive Cooperation of Retinoid Receptors and AP-1* , 2009, Journal of Biological Chemistry.

[12]  H. Ariga,et al.  PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions. , 2009, Molecular endocrinology.

[13]  Naoyuki Taniguchi,et al.  Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice. , 2006, Journal of biochemistry.

[14]  B. Williams,et al.  Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation. , 2013, Stem cell research.

[15]  Adrian V. Lee,et al.  A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis , 2011, BMC Cancer.

[16]  R. Baxter,et al.  Potentiation of Growth Factor Signaling by Insulin-like Growth Factor-binding Protein-3 in Breast Epithelial Cells Requires Sphingosine Kinase Activity* , 2009, The Journal of Biological Chemistry.

[17]  E. Ghigo,et al.  Dual effects of IGFBP‐3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  D. Yee,et al.  Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. , 2002, Cancer research.

[19]  R. Norton,et al.  Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding. , 2007, Biochemistry.

[20]  P. Yamada,et al.  Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. , 2009, American journal of physiology. Cell physiology.

[21]  C. Galet,et al.  IGFBP-3 is a metastasis suppression gene in prostate cancer. , 2011, Cancer research.

[22]  X. Shu,et al.  IGFBP3 mRNA expression in benign and malignant breast tumors , 2007, Breast Cancer Research.

[23]  D. Larhammar,et al.  Evolution of the insulin-like growth factor binding protein (IGFBP) family. , 2011, Endocrinology.

[24]  P. Cohen,et al.  Cellular Internalization of Insulin-like Growth Factor Binding Protein-3 , 2004, Journal of Biological Chemistry.

[25]  A. Ben-Ze'ev,et al.  Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-κB signaling that promotes colon cancer progression , 2013, Oncogene.

[26]  M. Boulton,et al.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). , 2011, Investigative ophthalmology & visual science.

[27]  Herbert Yu,et al.  Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics , 2009, Breast Cancer Research and Treatment.

[28]  D. Katsaros,et al.  Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer , 2004, International Journal of Gynecologic Cancer.

[29]  A. Seifalian,et al.  Biology of insulin-like growth factor binding protein-4 and its role in cancer (review). , 2006, International journal of oncology.

[30]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[31]  D. Yee,et al.  Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  G. Werther,et al.  IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells , 2014, Oncogene.

[33]  G. Fuller,et al.  An Interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and Integrin α5 Is Essential for IGFBP2-induced Cell Mobility* , 2006, Journal of Biological Chemistry.

[34]  B. Calabretta,et al.  Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells , 2005, Cell Death and Differentiation.

[35]  P. Fu,et al.  Prohibitin-2 Binding Modulates Insulin-like Growth Factor-binding Protein-6 (IGFBP-6)-induced Rhabdomyosarcoma Cell Migration* , 2013, The Journal of Biological Chemistry.

[36]  R. Sachidanandam,et al.  IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer , 2012, Journal of Ovarian Research.

[37]  S. Hilsenbeck,et al.  Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. , 1996, Journal of the National Cancer Institute.

[38]  W. Hong,et al.  Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development. , 2011, Endocrinology.

[39]  K. Siddle,et al.  Molecular Basis of Signaling Specificity of Insulin and IGF Receptors: Neglected Corners and Recent Advances , 2011, Front. Endocrin..

[40]  R. Baxter,et al.  Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. , 2004, The Journal of clinical endocrinology and metabolism.

[41]  T. Ekström,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Acute and Short-Term Effects of Growth Hormone on Insulin-Like Growth Factors and Their Binding Proteins: Serum Levels and Hepatic Messenger Ribon , 2022 .

[42]  K. Dittmann,et al.  Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK , 2008, Molecular Cancer.

[43]  C. Conover,et al.  Transforming Growth Factor‐β Regulation of the Insulin‐Like Growth Factor Binding Protein‐4 Protease System in Cultured Human Osteoblasts , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  R. Silber,et al.  Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells. , 2009, International journal of molecular medicine.

[45]  R. Baxter,et al.  Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling. , 2007, Archives of biochemistry and biophysics.

[46]  R. Baxter,et al.  Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin β Subunit* , 2000, The Journal of Biological Chemistry.

[47]  S. Goldstein,et al.  Accumulation of insulin‐like growth factor binding protein‐3 in conditioned medium of human fibroblasts increases with chronologic age of donor and senescence in vitro , 1993, Journal of cellular physiology.

[48]  G. Pirianov,et al.  Role of Insulin-Like Growth Factor Binding Protein-3 in 1, 25-Dihydroxyvitamin-D3-Induced Breast Cancer Cell Apoptosis , 2013, International journal of cell biology.

[49]  A. Hoeflich,et al.  Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? , 2001, Cancer research.

[50]  Dae-Yeol Lee,et al.  Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate Cancer* , 2010, The Journal of Biological Chemistry.

[51]  P. Fu,et al.  Insulin-like growth factor-binding protein-6 and cancer. , 2013, Clinical science.

[52]  K. Murthy,et al.  IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[53]  G. Fuller,et al.  IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  O. Fodstad,et al.  Association of insulin-like growth factor binding protein-3 expression with melanoma progression , 2006, Molecular Cancer Therapeutics.

[55]  R. Baxter,et al.  Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. , 1991, The Journal of clinical endocrinology and metabolism.

[56]  D. Seligson,et al.  IGFBP-3 Nuclear Localization Predicts Human Prostate Cancer Recurrence , 2013, Hormones and Cancer.

[57]  R. Baxter,et al.  Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.

[58]  S. Blumenthal.  From Insulin and Insulin-Like Activity to the Insulin Superfamily of Growth-Promoting Peptides: A 20th-Century Odyssey , 2010, Perspectives in biology and medicine.

[59]  Jeff M P Holly,et al.  Signalling pathways involved in the direct effects of IGFBP‐5 on breast epithelial cell attachment and survival , 2002, Journal of cellular biochemistry.

[60]  A. Hoeflich,et al.  IGFBP‐2 overexpression reduces the appearance of dysplastic aberrant crypt foci and inhibits growth of adenomas in chemically induced colorectal carcinogenesis , 2009, International journal of cancer.

[61]  D. Peehl,et al.  Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[62]  E. Canalis,et al.  Skeletal Growth Factors Regulate the Synthesis of Insulin-like Growth Factor Binding Protein-5 in Bone Cell Cultures (*) , 1995, The Journal of Biological Chemistry.

[63]  Stephen Twigg,et al.  Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit* , 1998, The Journal of Biological Chemistry.

[64]  C. Paraskeva,et al.  Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. , 2000, Cancer research.

[65]  R. Baxter,et al.  The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents , 2014, Oncogene.

[66]  S. Weintraub,et al.  Plasminogen activator inhibitor 1 - insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence , 2012, Proceedings of the National Academy of Sciences.

[67]  B. Conley,et al.  Endoglin regulates cancer-stromal cell interactions in prostate tumors. , 2011, Cancer research.

[68]  Ho-Yyoung Lee,et al.  Insulin‐like growth factor binding protein‐3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma , 2012, Cancer science.

[69]  J. Beattie,et al.  Insulin‐like growth factor binding protein (IGFBP)‐5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells , 2006, Journal of cellular physiology.

[70]  L. Zeng,et al.  Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells. , 2013, Experimental cell research.

[71]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 promotes glioma development and progression , 2007, Proceedings of the National Academy of Sciences.

[72]  R. Herbst,et al.  Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor–independent urokinase-type plasminogen activator inhibition , 2006, Molecular Cancer Therapeutics.

[73]  W. Kim,et al.  Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. , 2009, European journal of cancer.

[74]  A. Ashworth,et al.  Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment , 2006, Molecular Cancer Therapeutics.

[75]  D. Feldman,et al.  Unraveling insulin-like growth factor binding protein-3 actions in human disease. , 2009, Endocrine reviews.

[76]  S. Tejpar,et al.  TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations. , 2007, Experimental cell research.

[77]  J. Milbrandt,et al.  Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3. , 2007, Carcinogenesis.

[78]  Andrew S. Holmes,et al.  Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 , 2006, The Journal of cell biology.

[79]  R. Baxter,et al.  Inhibition of Insulin-like Growth Factor–Binding Protein-3 Signaling through Sphingosine Kinase-1 Sensitizes Triple-Negative Breast Cancer Cells to EGF Receptor Blockade , 2013, Molecular Cancer Therapeutics.

[80]  Y. Oh,et al.  Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells. , 2013, Lung cancer.

[81]  B. Leyland-Jones,et al.  Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[82]  C. McCaig,et al.  Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-β) in normal vs cancerous breast epithelial cells , 2002, British Journal of Cancer.

[83]  Sharon M Kelly,et al.  Cumulative mutagenesis of the basic residues in the 201-218 region of insulin-like growth factor (IGF)-binding protein-5 results in progressive loss of both IGF-I binding and inhibition of IGF-I biological action. , 2006, Endocrinology.

[84]  L. Hennighausen,et al.  Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. , 2003, Cancer research.

[85]  R. Baxter,et al.  Phosphorylation of insulin-like growth factor binding proteins , 1997, Molecular and Cellular Endocrinology.

[86]  M. Pollak.  The insulin and insulin-like growth factor receptor family in neoplasia: an update , 2012, Nature Reviews Cancer.

[87]  J. Frystyk.  Utility of Free IGF-I Measurements , 2007, Pituitary.

[88]  S. Jhanwar,et al.  Tumorigenesis and Neoplastic Progression Tumor-Associated Retinal Astrocytes Promote Retinoblastoma Cell Proliferation Through Production of IGFBP-5 , 2010 .

[89]  A. Renehan,et al.  Obesity and cancer risk: the role of the insulin–IGF axis , 2006, Trends in Endocrinology & Metabolism.

[90]  R. Taub,et al.  Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. , 2003, The Journal of clinical investigation.

[91]  A. Maitra,et al.  Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates with Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms , 2004, Clinical Cancer Research.

[92]  M. Hermann,et al.  Analysis of the cellular uptake and nuclear delivery of insulin‐like growth factor binding protein‐3 in human osteosarcoma cells , 2012, International journal of cancer.

[93]  S. S. Huang,et al.  Interactions of High Affinity Insulin-like Growth Factor-binding Proteins with the Type V Transforming Growth Factor-β Receptor in Mink Lung Epithelial Cells* , 1999, The Journal of Biological Chemistry.

[94]  R. Baxter.  Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. , 2000, American journal of physiology. Endocrinology and metabolism.

[95]  M. Waters,et al.  Patched1 Inhibits Epidermal Progenitor Cell Expansion and Basal Cell Carcinoma Formation by Limiting Igfbp2 Activity , 2010, Cancer Prevention Research.

[96]  S. Majid,et al.  Functional modulation of IGF-binding protein-3 expression in melanoma. , 2010, The Journal of investigative dermatology.

[97]  D. Clemmons,et al.  Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions* , 2000, The Journal of Biological Chemistry.

[98]  H. Werner,et al.  Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction. , 2013, Endocrinology.

[99]  S. Corroyer,et al.  Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition. , 2005, The Biochemical journal.

[100]  D. Marsh,et al.  Involvement of Insulin-like Growth Factor-binding Protein-3 in the Effects of Histone Deacetylase Inhibitor MS-275 in Hepatoma Cells , 2011, The Journal of Biological Chemistry.

[101]  S. Horvath,et al.  Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer , 2007, Proceedings of the National Academy of Sciences.

[102]  R. Koistinen,et al.  Placental protein 12 (PP12) in primary liver cancer and cirrhosis. , 1984, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[103]  D. Clemmons,et al.  Retinoic acid inhibits cell growth in HPV negative cervical carcinoma cells by induction of insulin-like growth factor binding protein-5 (IGFBP-5) secretion. , 1997, Biochemical and biophysical research communications.

[104]  E. Diamandis,et al.  Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. , 1996, British Journal of Cancer.

[105]  D. Andress.  Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. , 1998, The American journal of physiology.

[106]  W. El-Deiry,et al.  Epidermal Growth Factor Receptor Regulates Aberrant Expression of Insulin-Like Growth Factor-Binding Protein 3 , 2004, Cancer Research.

[107]  J. Shand,et al.  IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells , 2012, Journal of Cell Science.

[108]  Zhongming Zhao,et al.  Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells. , 2012, International journal of radiation oncology, biology, physics.

[109]  P. Fitzpatrick,et al.  Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer , 2009, British Journal of Cancer.

[110]  Baljit Singh,et al.  Insulin-like Growth Factor-independent Effects Mediated by a C-terminal Metal-binding Domain of Insulin-like Growth Factor Binding Protein-3* , 2004, Journal of Biological Chemistry.

[111]  G. Fuller,et al.  Overexpression of IGFBP5, but not IGFBP3, Correlates with the Histologic Grade of Human Diffuse Glioma: A Tissue Microarray and Immunohistochemical Study , 2006, Technology in cancer research & treatment.

[112]  R. Baxter,et al.  Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. , 1991, Endocrinology.

[113]  K. Hirata,et al.  Insulin‐like growth factor binding protein‐4 gene silencing in lung adenocarcinomas , 2011, Pathology international.

[114]  Y. Oh,et al.  Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling. , 2011, Cancer letters.

[115]  C. Holding,et al.  Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function , 2004, Journal of Cell Science.

[116]  S. Chakrabarty,et al.  Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells , 2006, Cancer biology & therapy.

[117]  Sarah K. Johnson,et al.  Insulin-like growth factor binding protein-5 influences pancreatic cancer cell growth. , 2009, World journal of gastroenterology.

[118]  D. Hochhauser,et al.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. , 2011, Cancer research.

[119]  S. Pyne,et al.  Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.

[120]  R. Baxter,et al.  TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells , 2013, Molecular and Cellular Endocrinology.

[121]  Akhilesh Pandey,et al.  Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome. , 2013, Biochimica et biophysica acta.

[122]  S. Bowen,et al.  Differential IGF‐independent effects of insulin‐like growth factor binding proteins (1–6) on apoptosis of breast epithelial cells , 1999, Journal of cellular biochemistry.

[123]  Yong Li,et al.  Structural and functional insights into nuclear receptor signaling. , 2010, Advanced drug delivery reviews.

[124]  Xuchen Cao,et al.  Expression level of insulin‐like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer , 2007, Cancer science.

[125]  M. Boulton,et al.  Insulin-Like Growth Factor Binding Protein-3 Mediates Vascular Repair by Enhancing Nitric Oxide Generation , 2009, Circulation research.

[126]  R. Baxter,et al.  IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments , 2013, Oncogene.

[127]  P. Cohen,et al.  Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. , 2004, Blood.

[128]  R. Huber,et al.  Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins , 2006, Proceedings of the National Academy of Sciences.

[129]  Y Li,et al.  Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[130]  R. Norton,et al.  Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding. , 2004, Journal of molecular endocrinology.

[131]  F. Boyle,et al.  Elevated Serum Insulin-Like Growth Factor Binding Protein-2 as a Prognostic Marker in Patients with Ovarian Cancer , 2004, Clinical Cancer Research.

[132]  Yunzhang Liu,et al.  IGF binding protein 3 exerts its ligand-independent action by antagonizing BMP in zebrafish embryos , 2011, Journal of Cell Science.

[133]  J. Schwander,et al.  Insulin-Like Growth Factor-Binding Protein , 1989, Definitions.

[134]  Mengzhong Liu,et al.  Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3 , 2012, Journal of Translational Medicine.

[135]  O. Debeir,et al.  Matrix metalloproteinase‐9 interplays with the IGFBP2–IGFII complex to promote cell growth and motility in astrocytomas , 2008, Glia.

[136]  P. Kondaiah,et al.  Regulation of protumorigenic pathways by Insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis , 2013, Molecular Cancer.

[137]  A. Ochiai,et al.  Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. , 2005, Biochemical and biophysical research communications.

[138]  Laura Sciacca,et al.  Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. , 2009, Endocrine reviews.

[139]  M. Rechler,et al.  Insulin‐like growth factor binding protein‐2 mediates the inhibition of DNA synthesis by transforming growth factor‐β in mink lung epithelial cells * † , 2002, Journal of cellular physiology.

[140]  Olaf Neumann,et al.  Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors , 2012, Hepatology.

[141]  D. Yee,et al.  Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. , 2008, The Journal of clinical investigation.

[142]  D. Clemmons,et al.  Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[143]  C. McCaig,et al.  A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells. , 2002, Biochemical and biophysical research communications.

[144]  D. Alderson,et al.  IGFBp‐3 prolongs the p53 response and enhances apoptosis following UV irradiation , 2000, International journal of cancer.

[145]  M. Ranke,et al.  Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.

[146]  G. Fuller,et al.  Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types , 2006, Modern Pathology.

[147]  R. Baxter,et al.  Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex. , 1990, The Journal of clinical endocrinology and metabolism.

[148]  R. Baxter,et al.  Molecular distribution of IGF binding protein-5 in human serum. , 2002, The Journal of clinical endocrinology and metabolism.

[149]  Z. Shao,et al.  Insulin‐like growth factor‐binding protein enhancement of insulin‐like growth factor‐i (IGF‐I)–mediated DNA synthesis and IGF‐I binding in a human breast carcinoma cell line , 1994, Journal of cellular physiology.

[150]  C. Burrows,et al.  Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide , 2011, Front. Endocrin..

[151]  I. Gram,et al.  The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[152]  S. Motoyama,et al.  IGFBP3 and BAG1 enhance radiation-induced apoptosis in squamous esophageal cancer cells. , 2011, Biochemical and biophysical research communications.

[153]  Y. Hannun,et al.  Integrin-associated Lyn Kinase Promotes Cell Survival by Suppressing Acid Sphingomyelinase Activity* , 2008, Journal of Biological Chemistry.

[154]  W. McGuire,et al.  Expression of insulin‐like growth factor binding proteins in human breast cancer correlates with estrogen receptor status , 1993, Journal of cellular biochemistry.

[155]  M. Soloff,et al.  Proliferation of DU145 prostate cancer cells is inhibited by suppressing insulin‐like growth factor binding protein‐2 , 2004, International journal of urology : official journal of the Japanese Urological Association.

[156]  M. Uemura,et al.  Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. , 2002, Cancer letters.

[157]  R. Baxter,et al.  Interaction between IGF binding protein-3 and TGFβ in the regulation of adipocyte differentiation. , 2012, Endocrinology.

[158]  I. Johnston,et al.  Evolution of Ancient Functions in the Vertebrate Insulin-Like Growth Factor System Uncovered by Study of Duplicated Salmonid Fish Genomes , 2013, Molecular biology and evolution.

[159]  P. Fu,et al.  Promotion of Cancer Cell Migration , 2007, Journal of Biological Chemistry.

[160]  V. Hwa,et al.  The Insulin-like Growth Factor-binding Protein (igfbp) Superfamily* , 2022 .

[161]  C. Scarlett,et al.  Prognostic Significance of Growth Factors and the Urokinase-Type Plasminogen Activator System in Pancreatic Ductal Adenocarcinoma , 2008, Pancreas.

[162]  Y. Yamaguchi,et al.  Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5 , 2010, Journal of cellular and molecular medicine.

[163]  J. Kuemmerle,et al.  IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-β1. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[164]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[165]  Hong Chen,et al.  Insulin-like growth factor binding protein-6 interacts with the thyroid hormone receptor α1 and modulates the thyroid hormone-response in osteoblastic differentiation , 2012, Molecular and Cellular Biochemistry.

[166]  Hong-Gang Wang,et al.  Sphingolipids: regulators of crosstalk between apoptosis and autophagy , 2013, Journal of Lipid Research.

[167]  R. Norton,et al.  IGF-binding proteins – the pieces are falling into place , 2005, Trends in Endocrinology & Metabolism.

[168]  R. Baxter.  Circulating binding proteins for the insulinlike growth factors , 1993, Trends in Endocrinology & Metabolism.

[169]  R. Baxter,et al.  Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. , 1988, Biochemical and biophysical research communications.

[170]  C. Conover,et al.  Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo. , 2011, Endocrinology.

[171]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[172]  Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. , 1997, The Journal of clinical endocrinology and metabolism.

[173]  H. Klocker,et al.  Insulin‐Like Growth Factor‐Binding Protein‐5 Enters Vesicular Structures but Not the Nucleus , 2007, Traffic.

[174]  D. Clemmons,et al.  Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[175]  R. Baxter,et al.  Amino- and carboxyl-terminal fragments of insulin-like growth factor (IGF) binding protein-3 cooperate to bind IGFs with high affinity and inhibit IGF receptor interactions. , 2003, Endocrinology.

[176]  C. McCaig,et al.  Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin , 2002, Journal of Cell Science.

[177]  Bernard Perbal,et al.  The CCN family of proteins: structure–function relationships , 2008, Trends in biochemical sciences.

[178]  C. Conover,et al.  Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. , 1992, Endocrinology.

[179]  R. Baxter,et al.  Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with Cancer , 2012, The Journal of Biological Chemistry.

[180]  M. Georgescu,et al.  PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. , 2005, Biochemical and biophysical research communications.

[181]  R. Baxter,et al.  Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. , 2006, Cancer research.

[182]  P. Cohen,et al.  Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. , 2008, Cancer research.

[183]  M. King,et al.  Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer Cells* , 2000, The Journal of Biological Chemistry.

[184]  Hong Chen,et al.  A novel interaction between insulin-like growth factor binding protein-6 and the vitamin D receptor inhibits the role of vitamin D3 in osteoblast differentiation , 2011, Molecular and Cellular Endocrinology.

[185]  J. Clifford,et al.  Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-α Regulate Transcriptional Signaling and Apoptosis* , 2000, The Journal of Biological Chemistry.

[186]  R. Norton,et al.  Insulin-Like Growth Factor Binding Proteins: A Structural Perspective , 2012, Front. Endocrin..

[187]  K. Michaelsen,et al.  Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. , 1995, The Journal of clinical endocrinology and metabolism.

[188]  M. Papa,et al.  Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. , 1993, The Journal of clinical endocrinology and metabolism.

[189]  R. Baxter,et al.  Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. , 2007, Molecular endocrinology.

[190]  C. Hagen,et al.  Insulinlike Growth Factor Binding Proteins , 1990 .

[191]  J. Edwards,et al.  Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-α , 2008 .

[192]  C. Hanemann,et al.  Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival , 2012, Oncogene.

[193]  M. Gleave,et al.  Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential. , 2005, Oncology reports.

[194]  L. Hennighausen,et al.  Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. , 2002, Cancer research.

[195]  S. Nakano,et al.  Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24* , 2007, Journal of Biological Chemistry.

[196]  Y. Shang,et al.  Signal Relay by Retinoic Acid Receptors α and β in the Retinoic Acid-induced Expression of Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[197]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[198]  R. Baxter,et al.  Role of N- and C-terminal Residues of Insulin-like Growth Factor (IGF)-binding Protein-3 in Regulating IGF Complex Formation and Receptor Activation* , 2004, Journal of Biological Chemistry.

[199]  J. Holly,et al.  IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology , 2008, Journal of Mammary Gland Biology and Neoplasia.

[200]  D. Salih,et al.  IGF‐independent effects of insulin‐like growth factor binding protein‐5 (Igfbp5) in vivo , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[201]  C. Roberts,et al.  IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. , 1992, Cancer research.

[202]  J. Steinle,et al.  DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose. , 2013, Investigative ophthalmology & visual science.

[203]  M. Westwood,et al.  Transforming growth factor-{beta} (TGF{beta}) receptors I/II differentially regulate TGF{beta}1 and IGF-binding protein-3 mitogenic effects in the human placenta. , 2010, Endocrinology.

[204]  M. Gleave,et al.  Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. , 2000, Cancer research.

[205]  F. López-Ríos,et al.  IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer , 2010, Oncogene.

[206]  C. Carlberg,et al.  Regulation of multiple insulin-like growth factor binding protein genes by 1α,25-dihydroxyvitamin D3 , 2005, Nucleic acids research.

[207]  R. Baxter,et al.  Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[208]  R. Baxter,et al.  Signaling through the Smad Pathway by Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells , 2002, The Journal of Biological Chemistry.

[209]  J. Shand,et al.  Molecular interactions in the insulin-like growth factor (IGF) axis: a surface plasmon resonance (SPR) based biosensor study , 2007, Molecular and Cellular Biochemistry.

[210]  三井 洋子.  ADAM28 is overexpressed in human breast carcinomas : implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3 , 2007 .

[211]  T. Burns,et al.  p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia. , 2005, The Journal of clinical endocrinology and metabolism.

[212]  B. Loftus,et al.  In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer , 2007, British Journal of Cancer.

[213]  H. Choi,et al.  Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex. , 2002, Biochemical and biophysical research communications.

[214]  R. Wildgruber,et al.  Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation. , 2013, Endocrinology.

[215]  D. Leroith,et al.  Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin‐like growth factor I , 2009, International journal of cancer.

[216]  P. Bosma,et al.  Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells , 2010, Fibrogenesis & tissue repair.